Somalogic stock.

Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and ...

Somalogic stock. Things To Know About Somalogic stock.

Jun 15, 2023 · Public companies currently own 5.5% of SomaLogic stock. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged. Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Nov 7, 2023 · Corporate: On October 4, 2023, the Company announced an all-stock merger with SomaLogic, which is expected to build a diversified leader in life sciences tools. The Company expects to close the ... SomaLogic expects revenue for the full year 2023 to range from $82 to $85 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Wednesday, November 8, 2023, to discuss its third quarter 2023 financial results. Those interested in listening to the conference call should register online here.

Filing of certain prospectuses and communications in connection with business combination transactions. Other. 0001104659-23-106611.pdf. 0001104659-23-106611.rtf. 0001104659-23-106611.xls. View HTML. Oct 04, 2023. 425. Filing of certain prospectuses and communications in connection with business combination transactions.

Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year Outlook. In connection with …Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since its IPO on the Shenzhen stock exchange, its share price has...

SomaLogic is a protein biomarker discovery and clinical diagnostics company located in Boulder, Colorado. It became listed on Nasdaq in September 2021 with a merger with the special-purpose acquisition company CM Life Sciences II, Inc. [2]Oct 4, 2023 · Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ... SomaLogic, Inc. is a commercial-stage proteomics company. The Company has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate ...Oct 4, 2023 · Stockholders representing approximately 16% of Standard BioTools common stock and approximately 1% of SomaLogic common stock, including the directors and executive officers of each company and affiliated investment funds, have entered into voting agreements in support of the transaction. Full 2023 Year Outlook

Somalogic story: Study finds proteomic risk scores for cardiovascular disease from SomaSignal Cardio DM tests could support physicians in managing patient outcomes and other headlines for Somalogic Stock

The average Somalogic stock price prediction forecasts a potential downside of 2.04% from the current SLGC share price of $2.45. What is SLGC's forecast return on assets (ROA) for 2023-2025? (NASDAQ: SLGC) forecast ROA is -9.99%, which is lower than the forecast US Health Information Services industry average of 8.41%.

Ark Investment Management has been accumulating the stock recently and owns 3.1% of SomaLogic stock. The current market cap of the company is $2.03B and the enterprise value is $1.8B. Over a long ...Oct 4, 2023 · SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools shareholders will own 43% of the ... View Your Watchlist. Stock analysis for SomaLogic Inc (SLGC:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and …Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...In the process, SomaLogic will receive up to $651 million in cash from CMLS II’s IPO earnings and common stock purchases from a handful of investors, bringing its total amount of cash available ...SomaLogic, Inc. (NASDAQ:SLGCW – Get Free Report)’s stock price rose 6.3% on Wednesday . The company traded as high as $0.17 and last traded at $0.17. Approximately 72,147 shares were traded during trading, an increase of 1,225% from the average daily volume of 5,446 shares. The stock had previously closed at $0.16. SomaLogic Stock PerformanceBOULDER, Colo. and SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire ...

Nov 18, 2022 · With the stock on the backfoot, Wood evidently thinks it offers good value. Ark Invest opened a new position in SomaLogic in Q3 and snapped up 11,017,672 shares. These are currently worth over $29 ... Nov 30, 2023 · A high-level overview of SomaLogic, Inc. (SLGC) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. SLGC Earnings Date and Information. SomaLogic last announced its earnings results on November 8th, 2023. The reported ($0.12) earnings per share (EPS) …Nov 24, 2023 · 4. How much of SomaLogic stock is owned by the general public? The general public, comprising individual investors, holds a 27% stake in SomaLogic. 5. What is the significance of private equity ownership? Private equity firms hold a 6.7% stake in SomaLogic, which could influence decision-making within the company. The SomaLogic team provided more than 28 million data points from the assay which will be combined with other available genetic, ... Recent action in Nvidia stock points to consolidation.

Oct 4, 2023 · Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...

Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …4. How much of SomaLogic stock is owned by the general public? The general public, comprising individual investors, holds a 27% stake in SomaLogic. 5. What is the significance of private equity ownership? Private equity firms hold a 6.7% stake in SomaLogic, which could influence decision-making within the company.SomaLogic boasts industry-leading reliability metrics that include sensitivity, specificity, and reproducibility, with coefficients of variation ~5%. Most protein assays excel in one or two areas. The SomaScan Assay is the first and only platform that enables 11,000 protein measurements from a 55-µL sample.SomaLogic to debut on Nasdaq as a leading publicly traded AI-data driven proteomics platform company. Business combination results in approximately $630 …SomaLogic Inc.’s SLGC, +10.78% stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to …Find the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing.Founders David Brunel, Larry Gold. Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name SomaLogic, Inc. Stock Symbol FRA:76X0. Company Type For Profit. Contact Email [email protected]. Phone Number 303-625-9000. SomaLogic operates as a protein biomarker discovery and clinical diagnostics company.

SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools …

SomaLogic to debut on Nasdaq as a leading publicly traded AI-data driven proteomics platform company. Business combination results in approximately $630 …

SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in ...Aug 15, 2022 · SomaLogic Reports Second Quarter 2022 Financial Results. August 15, 2022 at 4:05 PM EDT. PDF Version. Second quarter 2022 revenue of $14.1 million, bringing year to date revenue to $37.1 million. Reducing 2022 revenue guidance to $80-90 million to account for ongoing variability in core service business, macroeconomic and commercial factors. SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold …Jefferies Downgrades SomaLogic to Hold From Buy, Adjusts Price Target to $2.30 From $3.50. Oct. 05. MT. Canaccord Genuity Downgrades SomaLogic to Hold From Buy, Cuts Price Target to $2.50 From $5. Sep. 25. MT. Canaccord Genuity Adjusts Price Target on SomaLogic to $5 From $6, Maintains Buy Rating. Mar. 29. Shares of SomaLogic have tracked along with them, due to the all-stock nature of the deal, bringing SomaLogic's market capitalization down to $354.7 million, essentially the amount of cash the firm had at the end of the second quarter. "Based on stock prices, people don't seem to like this deal," said Kyle Mikson, an analyst with …Under the terms of the all-stock deal, SomaLogic investors are to receive 1.11 common shares of Standard BioTools stock for each SomaLogic common share they hold. When the merger closes, SomaLogic ...Aug 15, 2023 · Shares of SomaLogic (SLGC-0.35%) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock ... Find the latest Quantum Corporation (QMCO) stock quote, history, news and other vital information to help you with your stock trading and investing.Historical daily share price chart and data for SomaLogic since 2021 adjusted for splits and dividends. The latest closing stock price for SomaLogic as of November 29, 2023 is …SLGC Earnings Date and Information. SomaLogic last announced its earnings results on November 8th, 2023. The reported ($0.12) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.05. The business earned $22.05 million during the quarter, compared to analysts' expectations of $20.45 million.Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by ...

5 oct 2023 ... Somalogic shareholders will receive 1.11 shares of Standard BioTools' common stock for every share owned by SomaLogic. Standard Biotools ..."Based on stock prices, people don't seem to like this deal," said Kyle Mikson, an analyst with Canaccord Genuity who covers SomaLogic. "People knew Standard BioTools was going to buy something and SomaLogic makes a kind of sense, but I'm sure SomaLogic investors wanted a better premium and Standard BioTools investors wanted a more proven asset ...SomaLogic to deliver 7,000-plex SomaScan® Platform to researchers in attractive Chinese proteomics market. SHANGHAI and BOULDER, Colo., May 10, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, announced today that Biostar Technology Limited will be the company’s first authorized site in China …SomaLogic, Inc. (NasdaqGM:SLGC) entered into a definitive agreement to acquire to acquire Standard BioTools Inc. (NasdaqGS:LAB) from Viking Global Opportunities Illiquid Investments Sub-Master LP and Viking Global Opportunities Drawdown (Aggregator) LP, managed by Viking Global Investors LP and others for approximately $570 million in a reverse merger transaction on October 4, 2023.Instagram:https://instagram. high rate bondsoverstock bought bed bath and beyondhow to buy contracts on robinhoodqqq stock premarket Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...BOULDER, Colo., March 13, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, recently completed the 7,000-plex assay on and delivered data for 4,000 plasma samples from the China Kadoorie Biobank (CKB), one of the world’s largest prospective studies. when will iphone 15 pre order startnyse vz dividend Renowned investor Cathie Wood’s firm ARK Invest owns 11.02 million SLGC shares for a total value of $31.95 million, according to its latest 13F filing. The imputed share price was $2.90. SLGC has a 0.2% weight in ARK Invest and a 1.12% weight in ARK Genomic Revolution ETF (ARKG). ARK owns 4.97% of the company. best legal services plan Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by ...Incentive Stock Option Agreement 2009 Equity Incentive Plan SomaLogic, Inc. (the “Company”), pursuant to its 2009 Equity Incentive Plan (the “Plan”), hereby grants an Option to purchase shares of the Company’s common stock to you, the Optionee named below.Operator: Good afternoon, and welcome to SomaLogic's Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded for replay purposes. - Part 2